Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
Critical Reviews™ in Oncogenesis
SJR: 0.631 SNIP: 0.503 CiteScore™: 2.2

ISSN Imprimir: 0893-9675
ISSN On-line: 2162-6448

Critical Reviews™ in Oncogenesis

DOI: 10.1615/CritRevOncog.2016016084
pages 115-124

Gene Therapy for Lung Cancer

Humberto Lara-Guerra
Department of Thoracic and Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
Jack A. Roth
Department of Thoracic and Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

RESUMO

Gene therapy was originally conceived to treat monogenic diseases. The replacement of a defective gene with a functional gene can theoretically cure the disease. In cancer, multiple genetic defects are present and the molecular profile changes during the course of the disease, making the replacement of all defective genes impossible. To overcome these difficulties, various gene therapy strategies have been adopted, including immune stimulation, transfer of suicide genes, inhibition of driver oncogenes, replacement of tumor-suppressor genes that could mediate apoptosis or anti-angiogenesis, and transfer of genes that enhance conventional treatments such as radiotherapy and chemotherapy. Some of these strategies have been tested successfully in non-small-cell lung cancer patients and the results of laboratory studies and clinical trials are reviewed herein.

Palavras-chave: lung cancer, gene therapy

Articles with similar content:

The Potential of CpG Oligodeoxynucleotides as Mucosal Adjuvants
Critical Reviews™ in Immunology, Vol.21, 2001, issue 1-3
Heather L. Davis, Risini D. Weeratna, Paul J. Payette
Drug Combinations with HDAC Inhibitors in Antitumor Therapy
Critical Reviews™ in Oncogenesis, Vol.20, 2015, issue 1-2
Noemi Arrighetti, Cristina Corno, Laura Gatti
Critical Aspects in Rationale Design of Fluorouracil-Based Adjuvant Therapies for the Management of Colon Cancer
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.29, 2012, issue 2
Vivek Ranjan Sinha, Honey
Genomic Pathology and Cancer Biomarkers: Prostate Cancer
Critical Reviews™ in Oncogenesis, Vol.22, 2017, issue 5-6
Kenneth A. Iczkowski
Current Vaccination Strategies for the Treatment of B-Cell Lymphoma and Multiple Myeloma
Critical Reviews™ in Immunology, Vol.29, 2009, issue 5
Nurit Hollander